Young Mo Kang

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy

Ki Young Choi, Hong Yeol Yoon, Jong‐Ho Kim et al. · ACS Nano · 2011 · 395 citations

Pharmacy, Oncology, Pharmacology +17

High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry

Celi Sun, Julio E. Molineros, Loren L. Looger et al. · Nature Genetics · 2016 · 268 citations · Full text

Life Sciences, Genetics, Immunology +14

Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis

Roun Heo, Dong Gil You, Wooram Um et al. · Biomaterials · 2017 · 196 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +16

In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery

V. G. Deepagan, Seunglee Kwon, Dong Gil You et al. · Biomaterials · 2016 · 192 citations

Pharmacy, Oncology, Pharmacology +14